Lamivudine (lamivudine): Reviews and patient testimonials

Lamivudine 100 mg film-coated tablets

Lamivudine 100 mg film-coated tablets is indicated for the treatment of chronic hepatitis B in adults with:

▪ compensated liver disease with evidence of active viral replication, persistently elevated serum alanine aminotransferase (ALT) levels and histological evidence of active liver inflammation and/or fibrosis. Initiation of lamivudine treatment should only be considered when the use of an alternative antiviral agent with a higher genetic barrier is not available or appropriate (see section 5.1).

▪ decompensated liver disease in combination with a second agent without cross-resistance to lamivudine.

Lamivudine 100 mg Film-coated Tablets

Lamivudine is indicated for the treatment of chronic hepatitis B in adults with:

• compensated liver disease with evidence of active viral replication, persistently elevated serum alanine aminotransferase (ALT) levels and histological evidence of active liver inflammation and/or fibrosis. Initiation of lamivudine treatment should only be considered when the use of an alternative antiviral agent with a higher genetic barrier is not available or appropriate (see in section 5.1).

• decompensated liver disease in combination with a second agent without cross-resistance to lamivudine.

Lamivudine Accord 100 mg Film-coated tablets

Lamivudine Accord is indicated for the treatment of chronic hepatitis B in adults with:

▪ compensated liver disease with evidence of active viral replication, persistently elevated serum alanine aminotransferase (ALT) levels and histological evidence of active liver inflammation and/or fibrosis. Initiation of lamivudine treatment should only be considered when the use of an alternative antiviral agent with a higher genetic barrier is not available or appropriate (see section 5.1).

▪ decompensated liver disease in combination with a second agent without cross-resistance to lamivudine.

Lamivudine Accord 150 mg Film-coated tablets

Lamivudine Accord is indicated as part of antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infected adults and children.

Lamivudine Accord 300 mg Film-coated tablets

Lamivudine Accord is indicated as part of antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infected adults and children.

Lamivudine Mylan 150 mg Film-coated Tablets

Lamivudine Mylan is indicated as part of antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infected adults and children.

Lamivudine Mylan 300 mg Film-coated Tablets

Lamivudine Mylan is indicated as part of antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infected adults and children.

Lamivudine Sandoz 100 mg Film-coated Tablets

Lamivudine is indicated for the treatment of chronic hepatitis B in adults with:

• compensated liver disease with evidence of active viral replication, persistently elevated serum alanine aminotransferase (ALT) levels and histological evidence of active liver inflammation and/or fibrosis. Initiation of lamivudine treatment should only be considered when the use of an alternative antiviral agent with a higher genetic barrier is not available or appropriate.

• decompensated liver disease in combination with a second agent without cross-resistance to lamivudine.

Lamivudine Tablet 150mg

Lamivudine is indicated as part of antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infected adults and children.

Lamivudine Tablet 300mg

Lamivudine is indicated as part of antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infected adults and children.